Big Pharma has long known that blocking an enzyme called Cathepsin K (CatK) stops bone loss and prevents osteoporosis.
But the industry’s quest to bring anti-CatK drugs to market has been a spectacular failure. In clinical trials, these drugs have caused so many horrific complications that the FDA has refused to approve any of them.
… Read More